Hadassah becomes first Israeli hospital to join global research network

“We will be able to bring new solutions, new treatments to be implemented here in Hadassah,” said Prof. Eyal Mishani, head of the Research & Development division at Hadassah Medical Center.

By
September 2, 2018 17:45
2 minute read.
Hadassah University Medical Center

Hadassah University Medical Center. (photo credit: AVI HAYOUN)

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analysis from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

Hadassah University Medical Center has become the first Israeli medical institution to join a worldwide research network that promises to optimize the nature and efficiency of clinical research and medical discoveries.

Prof. Eyal Mishani, head of the Research & Development Division at Hadassah Medical Center told The Jerusalem Post on Sunday that the network platform, which is unparalleled in nature and size, will prove beneficial for both patients and medical staff as the center will gain access to large quantities of data supplied by other hospitals and medical companies.

“We will be able to bring new solutions, new treatments to be implemented here in Hadassah,” said Mishani. “Let’s assume that there is a huge pharmaceutical company that develops a new drug. We will be the first to know and we can use it for the benefit our patients.”

TriNetX is a global health research network of healthcare organizations, biopharmaceutical companies and contract research organizations which aims to increase the efficiency of clinical trials and enable medical discoveries through the gathering and sharing of real world data, gained outside of controlled medical trials.

Medical institutions from 15 countries, representing approximately 135 million patients, currently make up the TriNetX network, whose headquarters are situated in Cambridge, Massachusetts.

The network combines real-time access to clinical data with cutting edge analytical technology, thereby enabling researchers to speedily answer complex research questions regarding treatment effectiveness.

Although Hadassah will be submitting clinical data to the network based on the treatment of its own patients, Prof. Mishani stressed the critical importance given to maintaining the privacy of patients’ personal information by the medical center.

“Safety was one of the first things that we considered. TriNetX does everything that should be done to protect personal information,” he said, adding that Hadassah should be able to gain access to the system and its benefits later this month.

Director of the Hadassah Medical Organization Prof. Zeev Rotstein praised the new opportunities for enhanced medical cooperation presented by the network.

“Hadassah Medical Center, with its new framework, lies at the forefront of research, both in Israel and internationally,” he said. “The doctors and researchers in the hospital very proudly represent the significant achievements that they contribute to the advancement of future medicine.

“I am convinced that the new partnership will lead us to new and impressive achievements,” he added.

Gadi Lachman, CEO of TriNetX and a graduate of Tel Aviv University, welcomed the addition of Hadassah to the network.

“We are excited to have Hadassah Medical Center become part of our growing international presence. We believe the added exposure to our pharmaceutical members will prove enormously beneficial for Hadassah,” Lachman said.


Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

July 16, 2019
Dr. Ruth, ‘Green Book’ producer to attend Jerusalem Film Festival

By HANNAH BROWN

Cookie Settings